Synthesis of bis-spirocyclic derivatives of 3-azabicyclo[3.1.0]hexane via cyclopropene cycloadditions to the stable azomethine ylide derived from Ruhemann's purple

• Alexander S. Filatov,
• Olesya V. Khoroshilova,
• Anna G. Larina,
• Vitali M. Boitsov and
• Alexander V. Stepakov

Beilstein J. Org. Chem. 2022, 18, 769–780, doi:10.3762/bjoc.18.77

• found in natural compounds [9][10][11]. It is used in pharmaceuticals [12][13][14][15] and key intermediates [16][17]. Compounds containing a 3-azabicyclo[3.1.0]hexane moiety are antagonists of morphine-induced antinociception [18], histone deacetylase inhibitors [13], and opioid receptor antagonists

Synthesis of esters of diaminotruxillic bis-amino acids by Pd-mediated photocycloaddition of analogs of the Kaede protein chromophore

• Esteban P. Urriolabeitia,
• Pablo Sánchez,
• Alexandra Pop,
• Cristian Silvestru,
• Eduardo Laga,
• Ana I. Jiménez and
• Carlos Cativiela

Beilstein J. Org. Chem. 2020, 16, 1111–1123, doi:10.3762/bjoc.16.98

• pain [7][8][9][10]. Moreover, alternative mechanisms to explain the antinociception of truxillic compounds have also been reported [11][12] and have generated intense debate. In addition, truxillic derivatives have shown remarkable activity as hepato-protective agents [13] and they also have

A chemically contiguous hapten approach for a heroin–fentanyl vaccine

• Yoshihiro Natori,
• Candy S. Hwang,
• Lucy Lin,
• Lauren C. Smith,
• Bin Zhou and
• Kim D. Janda

Beilstein J. Org. Chem. 2019, 15, 1020–1031, doi:10.3762/bjoc.15.100

• fentanyl-like domains. Analysis of the results obtained by SPR and ELISA revealed trends in antibody affinity and titers for heroin and fentanyl based on epitope size and linker location. In antinociception studies, the best performing vaccines offered comparable protection against heroin as our benchmark

• report of such a strategy in the opioid–drug–vaccine field. Keywords: antinociception; fentanyl; hapten; heroin; vaccine; Introduction In 2016, the Centers for Disease Control (CDC) estimated that approximately 20.4% of the U.S. population (e.g., 50 million people) was suffering from chronic pain [1

• protocol detailed in our previous study, except this study incorporated an extra boost at week 7, bleed at week 8, and antinociception at week 9 [13]. The vaccination schedule is shown in Figure 4. Mice were bled at weeks 3, 5, and 8 using submandibular puncture with a single-use lancet to collect 100–500